Free Newsletter
Drug delivery vehicles' shape could determine efficacy
A group of researchers at the University of Pennsylvania say that string-like nanoparticles survive longer than spherically shaped nanoparticles, which leads them to believe that the right shape is a key concern in designing new delivery vehicles for drugs. Dennis Discher and colleagues at the University of Pennsylvania say that string-like nanoparticles circulated for up to a week in rodents, significantly longer than the carbon nanotubes that have been studied in depth. Their work appears in the April issue of the journal Nature Nanotechnology.
- read the UPI's report on drug delivery vehicles
Related Articles:
Nanotech grows more common in drug dev research. Report
FDA to gather more info on bio-nano. Report
Nanoparticle programs advance the science of small. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




